BioSig Technologies, Inc. STEX Noncontrolling interests in subsidiaries
Noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries?
- BioSig Technologies, Inc. (STEX) reported noncontrolling interests in subsidiaries of $256K in Q1 2026.
- How has BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
- BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries increased by 782.8% year-over-year, from $29K to $256K.
- What is the long-term trend for BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s noncontrolling interests in subsidiaries has grown at a -47.5% compound annual growth rate (CAGR), from $802K to $32K.
- What does noncontrolling interests in subsidiaries mean?
- This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.